Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Pelletier

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2020
Comparison of rituximab originator (MabThera<sup>®</sup>) to biosimilar (Truxima<sup>®</sup>) in patients with multiple sclerosisThomas Perez, Audrey Rico, Clémence Boutière, et al.
Medical Education|August 24, 2006
Assessment of clinical reasoning in the context of uncertainty: the effect of variability within the reference panelBernard Charlin, Robert Gagnon, Jean Pelletier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 24, 2021
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With RituximabMarine Perriguey, Adil Maarouf, Jan-Patrick Stellmann, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 8, 2015
Brain functional plasticity at rest and during action in multiple sclerosis patientsAnthony Faivre, Audrey Rico, Wafaa Zaaraoui, et al.
Plos One|July 6, 2007
Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluidNorbert W Lutz, Angèle Viola, Irina Malikova, et al.
BMC Neurology|April 9, 2014
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indicesKarine Baumstarck, Mohamed Boucekine, Laurent Boyer, et al.
Journal of the Neurological Sciences|April 25, 2006
Functional magnetic resonance imaging and cognition at the very early stage of MSBertrand Audoin, My Van Au Duong, Irina Malikova, et al.
Journal of Neuropsychology|May 26, 2017
Effects of cognitive impairment on prosodic parameters of speech production planning in multiple sclerosisCéline De Looze, Noémie Moreau, Laurent Renié, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2010
Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosisBertrand Audoin, Wafaa Zaaraoui, Françoise Reuter, et al.
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2020
Comparison of rituximab originator (MabThera<sup>®</sup>) to biosimilar (Truxima<sup>®</sup>) in patients with multiple sclerosisThomas Perez, Audrey Rico, Clémence Boutière, et al.
Medical Education|August 24, 2006
Assessment of clinical reasoning in the context of uncertainty: the effect of variability within the reference panelBernard Charlin, Robert Gagnon, Jean Pelletier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 24, 2021
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With RituximabMarine Perriguey, Adil Maarouf, Jan-Patrick Stellmann, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 8, 2015
Brain functional plasticity at rest and during action in multiple sclerosis patientsAnthony Faivre, Audrey Rico, Wafaa Zaaraoui, et al.
Plos One|July 6, 2007
Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluidNorbert W Lutz, Angèle Viola, Irina Malikova, et al.
BMC Neurology|April 9, 2014
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indicesKarine Baumstarck, Mohamed Boucekine, Laurent Boyer, et al.
Journal of the Neurological Sciences|April 25, 2006
Functional magnetic resonance imaging and cognition at the very early stage of MSBertrand Audoin, My Van Au Duong, Irina Malikova, et al.
Journal of Neuropsychology|May 26, 2017
Effects of cognitive impairment on prosodic parameters of speech production planning in multiple sclerosisCéline De Looze, Noémie Moreau, Laurent Renié, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2010
Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosisBertrand Audoin, Wafaa Zaaraoui, Françoise Reuter, et al.
Pageof 20